A measles case linked to a recent flight has highlighted Idaho's dangerously low vaccination rates. The state currently maintains an MMR vaccination rate of only 78.5 percent.
This figure sits significantly below the 95 percent coverage required to stop the virus from spreading through communities. Health experts state that this 95 percent threshold is the level needed to maintain herd immunity and prevent the virus from moving onward.
High rates of vaccine exemptions further limit Idaho's potential coverage. Based on current exemption levels, the maximum MMR vaccination coverage the state could potentially attain is only around 85 percent. This gap between the 85 percent cap and the 95 percent target leaves a significant portion of the population vulnerable.
Idaho has recorded nine measles cases since the start of 2026. According to a state tracking site, every identified case involved individuals who were either unvaccinated or had an unknown vaccination status.
Potential for undetected transmission
Health officials fear more cases may be circulating without detection. Last August, the state reported three cases, including two in neighboring northern counties.
At the time of those reports, health officials noted there was no clear link between the two cases in the northern part of the state. This lack of a traceable connection suggests the virus may be more widespread than official counts indicate.
“Without any link between these two confirmed cases in north Idaho or travel outside of their communities, it’s reasonable to suspect that there is more measles circulating,” said Christine Hahn, state epidemiologist and Division of Public Health medical director at DHW.
Hahn noted that cases in other states have distributed widely. While no connection to the recent airplane case has been confirmed, officials are urging residents to check their immunization records.
The Idaho health department recommends two doses of the MMR vaccine, which is 97 percent effective. The vaccine is routinely recommended for children aged 12–15 months, with a second dose between ages 4 and 6.
Health officials noted that the protection provided by the vaccine is considered lifelong. The department continues to advise all residents to ensure they have completed the full series to prevent future outbreaks.
